Form 8-K - Current report:
SEC Accession No. 0001104659-23-019581
Filing Date
2023-02-13
Accepted
2023-02-13 14:59:15
Documents
41
Period of Report
2023-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm236582d1_8k.htm   iXBRL 8-K 28406
2 EXHIBIT 99.1 tm236582d1_ex99-1.htm EX-99.1 37558
6 GRAPHIC tm236582d1_ex99-1img001.jpg GRAPHIC 110330
7 GRAPHIC tm236582d1_ex99-1img002.jpg GRAPHIC 216456
8 GRAPHIC tm236582d1_ex99-1img003.jpg GRAPHIC 204008
9 GRAPHIC tm236582d1_ex99-1img004.jpg GRAPHIC 160315
10 GRAPHIC tm236582d1_ex99-1img005.jpg GRAPHIC 101209
11 GRAPHIC tm236582d1_ex99-1img006.jpg GRAPHIC 147504
12 GRAPHIC tm236582d1_ex99-1img007.jpg GRAPHIC 179827
13 GRAPHIC tm236582d1_ex99-1img008.jpg GRAPHIC 175401
14 GRAPHIC tm236582d1_ex99-1img009.jpg GRAPHIC 141642
15 GRAPHIC tm236582d1_ex99-1img010.jpg GRAPHIC 137215
16 GRAPHIC tm236582d1_ex99-1img011.jpg GRAPHIC 141535
17 GRAPHIC tm236582d1_ex99-1img012.jpg GRAPHIC 132713
18 GRAPHIC tm236582d1_ex99-1img013.jpg GRAPHIC 132268
19 GRAPHIC tm236582d1_ex99-1img014.jpg GRAPHIC 126434
20 GRAPHIC tm236582d1_ex99-1img015.jpg GRAPHIC 115244
21 GRAPHIC tm236582d1_ex99-1img016.jpg GRAPHIC 118242
22 GRAPHIC tm236582d1_ex99-1img017.jpg GRAPHIC 143020
23 GRAPHIC tm236582d1_ex99-1img018.jpg GRAPHIC 140358
24 GRAPHIC tm236582d1_ex99-1img019.jpg GRAPHIC 241807
25 GRAPHIC tm236582d1_ex99-1img020.jpg GRAPHIC 177855
26 GRAPHIC tm236582d1_ex99-1img021.jpg GRAPHIC 176391
27 GRAPHIC tm236582d1_ex99-1img022.jpg GRAPHIC 153146
28 GRAPHIC tm236582d1_ex99-1img023.jpg GRAPHIC 73653
29 GRAPHIC tm236582d1_ex99-1img024.jpg GRAPHIC 124164
30 GRAPHIC tm236582d1_ex99-1img025.jpg GRAPHIC 150755
31 GRAPHIC tm236582d1_ex99-1img026.jpg GRAPHIC 137215
32 GRAPHIC tm236582d1_ex99-1img027.jpg GRAPHIC 153162
33 GRAPHIC tm236582d1_ex99-1img028.jpg GRAPHIC 92293
  Complete submission text file 0001104659-23-019581.txt   5908179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA anvs-20230213.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE anvs-20230213_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anvs-20230213_pre.xml EX-101.PRE 22599
35 EXTRACTED XBRL INSTANCE DOCUMENT tm236582d1_8k_htm.xml XML 3707
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 23617453
SIC: 2834 Pharmaceutical Preparations